Brief: Imricor Medical Systems Says Ethics Committee At Lausanne University Hospital Approved Visabl-Afl Clinical Trial
08/03/2024 01:38
March 8 (Reuters) - Imricor Medical Systems Inc
IMR.AX :
* ETHICS COMMITTEE AT LAUSANNE UNIVERSITY HOSPITAL APPROVED
VISABL-AFL CLINICAL TRIAL
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion